Che-Ming Teng Selected Research

Che-Ming Teng Research Topics

Disease

57	Neoplasms (Cancer) 07/2021 - 02/2003
14	Prostatic Neoplasms (Prostate Cancer) 02/2012 - 09/2002
11	Breast Neoplasms (Breast Cancer) 01/2020 - 06/2004
10	Hepatocellular Carcinoma (Hepatoma) 01/2017 - 03/2005
9	Colorectal Neoplasms (Colorectal Cancer) 11/2015 - 07/2008
7	Leukemia 04/2017 - 05/2004
6	Lung Neoplasms (Lung Cancer) 07/2021 - 07/2007
6	Neoplasm Metastasis (Metastasis) 03/2013 - 11/2007
5	Inflammation (Inflammations) 10/2014 - 07/2002
5	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2014 - 06/2007
4	Hypoxia (Hypoxemia) 09/2015 - 09/2009
4	Adenocarcinoma of Lung 08/2012 - 02/2008
3	Pancreatic Neoplasms (Pancreatic Cancer) 01/2019 - 08/2013
3	Hyperplasia 01/2016 - 06/2003
3	Vascular System Injuries 01/2016 - 06/2003
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2015 - 01/2012
3	Thrombosis (Thrombus) 08/2013 - 09/2006
2	Ovarian Neoplasms (Ovarian Cancer) 01/2017 - 01/2016
2	Body Weight (Weight, Body) 01/2017 - 01/2012
2	Carcinogenesis 08/2012 - 01/2011
2	Kidney Neoplasms (Kidney Cancer) 01/2012 - 04/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 09/2009 - 12/2003
2	Mitochondrial Diseases (Mitochondrial Disease) 02/2008 - 01/2005
2	Acute Promyelocytic Leukemia 10/2005 - 01/2005
1	Polyploidy 01/2016
1	Carcinoma (Carcinomatosis) 01/2016
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 07/2015
1	B-Cell Lymphoma (Lymphoma, B Cell) 03/2015

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 07/2021 - 01/2005
10	Histone Deacetylase InhibitorsIBA 01/2019 - 01/2011
7	TubulinIBA 08/2015 - 09/2002
7	denbinobinIBA 01/2013 - 01/2005
7	Hormones (Hormone)IBA 02/2012 - 02/2004
6	Histone Deacetylases (Histone Deacetylase)IBA 01/2016 - 01/2011
5	Antineoplastic Agents (Antineoplastics)IBA 01/2017 - 07/2007
4	3- (1- benzenesulfonyl- 2,3- dihydro- 1H- indol- 5- yl)- N- hydroxyacrylamideIBA 01/2019 - 01/2012
4	dendrophenolIBA 01/2017 - 07/2008
4	NF-kappa B (NF-kB)IBA 01/2012 - 10/2005
4	evodiamineIBA 09/2009 - 05/2004
4	IndazolesIBA 01/2006 - 12/2003
3	Phosphotransferases (Kinase)IBA 01/2017 - 07/2011
3	Cardiac GlycosidesIBA 01/2017 - 09/2002
3	CaspasesIBA 01/2016 - 02/2008
3	Cadherins (E-Cadherin)IBA 07/2014 - 01/2011
2	Notch1 ReceptorIBA 01/2020 - 01/2016
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2019 - 08/2013
2	Protein Kinases (Protein Kinase)IBA 01/2017 - 07/2008
2	Antimitotic AgentsIBA 01/2016 - 02/2008
2	3,6- bis(5- chloro- 2- piperidyl)- 2,5- piperazinedioneIBA 01/2016 - 08/2013
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 09/2015 - 08/2013
2	YXM110IBA 09/2015 - 09/2013
2	Vincristine (Oncovin)FDA LinkGeneric 07/2015 - 09/2002
2	Vorinostat FDA Link 07/2015 - 01/2011
2	EnzymesIBA 11/2014 - 02/2010
2	matrigelIBA 10/2014 - 07/2011
2	CarrageenanIBA 10/2014 - 07/2013
2	Histones (Histone)IBA 07/2014 - 01/2014
2	Caspase 3 (Caspase-3)IBA 03/2014 - 02/2008
2	Type II DNA Topoisomerases (Topoisomerase II)IBA 01/2014 - 01/2012
2	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2014 - 06/2007
2	antofineIBA 08/2012 - 07/2011
2	cryptopleurineIBA 08/2012 - 07/2011
2	neotanshinlactoneIBA 07/2012 - 03/2010
2	aciculatinIBA 01/2012 - 01/2012
2	Thrombin FDA Link 04/2011 - 09/2006
2	CytokinesIBA 01/2010 - 05/2005
2	2-phenyl-4-oxohydroquinolineIBA 02/2008 - 06/2007
2	bromovulone IIIIBA 10/2005 - 04/2004
2	ProstaglandinsIBA 10/2005 - 01/2005
2	Paclitaxel (Taxol)FDA LinkGeneric 05/2005 - 09/2002
2	AlkaloidsIBA 01/2005 - 05/2004
2	AndrogensIBA 02/2004 - 09/2002
2	Ouabain (G Strophanthin)IBA 02/2004 - 09/2002
1	BenzamidesIBA 07/2021
1	AfatinibIBA 07/2021
1	quinolineIBA 04/2017
1	lanatoside CIBA 01/2017
1	Digoxin (Digitek)FDA LinkGeneric 01/2017
1	Anti-Arrhythmia AgentsIBA 01/2017
1	MicroRNAs (MicroRNA)IBA 11/2016
1	Estrogens (Estrogen)FDA Link 04/2016
1	integrin-linked kinaseIBA 04/2016
1	Small Interfering RNA (siRNA)IBA 04/2016
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2016
1	3- (1- (4- methoxybenzenesulfonyl)- 2,3- dihydro- 1H- indol- 5- yl)- N- hydroxyacrylamideIBA 01/2016
1	LigandsIBA 01/2016
1	Cisplatin (Platino)FDA LinkGeneric 01/2016
1	Eukaryotic Initiation Factor-4EIBA 09/2015
1	Carrier Proteins (Binding Protein)IBA 09/2015
1	diphenyl (biphenyl)IBA 08/2015
1	compound 21IBA 08/2015
1	BenzenesulfonamidesIBA 08/2015
1	dactolisibIBA 02/2015
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 02/2015
1	TOR Serine-Threonine KinasesIBA 02/2015

Therapy/Procedure

17	Therapeutics 01/2017 - 09/2002
4	Drug Therapy (Chemotherapy) 04/2017 - 01/2005
2	Oral Administration 04/2017 - 01/2016
2	Radiotherapy 11/2014 - 03/2013
2	Aftercare (After-Treatment) 01/2012 - 10/2005